Cancer · 1980 · 159 citations · 17 references
Life SciencesImmunologyOncologyCancer ImmunologyHypersensitivityImmunotherapyCancer ImmunotherapyCell-mediated ImmunityDelayed-type HypersensitivityHumoral ImmunityImmunosuppressionDelayed Cutaneous HypersensitivityDelayed Hypersensitivity ReactionsHumoral Immunity ImpairmentImmunotherapy For Gastric CancerLymphocyte PhysiologySurvival RatesT-cell Mediated Immunity
Immunotherapy with daily intradermal injections of OK-432, penicillin- and heat-treated lyophilized powder of Su-strain of streptococcus pyogens A3, for over a period of four weeks resulted in quantitative and qualitative effectiveness on impaired cell-mediated immunity even in many patients with far advanced cancer of the stomach or lung. In vitro lymphocyte studies following immunotherapy with OK-432 demonstrated restoration of circulating lymphocyte counts to more than 1,500/microliters, a level associated with normalized subpopulation constitution and increases of phytomitogen blastogenesis. Furthermore, a delayed hypersensitivity skin reaction to PPD was boosted or converted into a positive reaction in some cases. There was, however, no detectable, definite effect on humoral immunity after the therapy. Survival rates at three and six months after the initiation of immunochemotherapy using OK-432 and another chemotherapeutic agent, 5-fluorouracil, in 40 patients with cancer were significantly longer than those of matched control patients given chemotherapy alone.
17
CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA
WILLIAM B. COLEY · Annals of Surgery · 1891 · 693 citations · Full text
Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.
Foley Ej · PubMed · 1953 · 690 citations
Medicine, Immunology, Oncology +14
Impaired immunologic reactivity and recurrence following cancer surgery
Frederick R. Eilber, Donald L. Morton · Cancer · 1970 · 667 citations
Life Sciences, Immunology, Oncology +14
ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIA
G Mathé, Jeanne Amiel, L Schwarzenberg et al. · The Lancet · 1969 · 613 citations
ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENT
L. E. Böttiger, G Boman, Gustav Eklund et al. · The Lancet · 1980 · 398 citations
Medicine, Gynecology, Obstetrics +14